Masaya Uno, Rie Matsuo, Naoki Maezawa, & Tomoyasu Kato. (2023). Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer. Korean Society of Obstetrics and Gynecology.
Chicago Style (17th ed.) CitationMasaya Uno, Rie Matsuo, Naoki Maezawa, and Tomoyasu Kato. Evaluation of Follow-up Observation Using Human Epididymis Protein 4, a Tumor Marker, in Patients with Ovarian Cancer. Korean Society of Obstetrics and Gynecology, 2023.
MLA (9th ed.) CitationMasaya Uno, et al. Evaluation of Follow-up Observation Using Human Epididymis Protein 4, a Tumor Marker, in Patients with Ovarian Cancer. Korean Society of Obstetrics and Gynecology, 2023.
Warning: These citations may not always be 100% accurate.